Abbott Laboratories (NYSE:ABT) Position Cut by Aull & Monroe Investment Management Corp
Aull & Monroe Investment Management Corp trimmed its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 2.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,551 shares of the healthcare product maker’s stock after selling 553 shares during the quarter. […]